Diastolic Deceleration Area in Early-onset FGR

Last updated: April 27, 2023
Sponsor: Orthogyn Medical Center, Bulgaria
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anemia

Treatment

DDA Doppler

Clinical Study ID

NCT05820464
DDA1
  • Ages 18-48
  • Female

Study Summary

DDA is a new Doppler parameter aiming to assess fetal well-being in-utero. Early-onset SGR is a specific subgroup of fetuses where the clinical application of this Doppler modality could play an important role in the detection of hypoxia, anemia, and brain-sparing.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • absence of fetal abnormalities and/or genetic conditions;
  • single pregnancy;
  • fetal growth restriction (FGR) < 10%, according to the INTERGROWTH 21st nomograms,appearing before 32nd week of gestation

Exclusion

Exclusion Criteria:

  • documented fetal abnormalities and/or genetic conditions in the course of thepregnancy;
  • multiple pregnancy;
  • absence of fetal growth restriction (FGR) < 10%, according to the INTERGROWTH 21stnomograms before 32nd week of gestation

Study Design

Total Participants: 300
Treatment Group(s): 1
Primary Treatment: DDA Doppler
Phase:
Study Start date:
April 19, 2022
Estimated Completion Date:
April 01, 2024

Connect with a study center

  • Orthogyn Medical and Dental Center

    Sofia, 1606
    Bulgaria

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.